Sakara Elevates Wellness with New Premium Supplements Line

Good Evening Readers! We will be covering these today 🔽 

• Sakara Introduces New Premium Supplements Line

• MYndspan has Partnered with MEGIN

• LINZESS® experienced an 11% growth in prescription demand

• Warby Parker Inc. has released its financial results for the fourth quarter

• Dermatologists express skepticism over use of supplements for skin

Sakara Elevates Wellness with New Premium Supplements Line

Just months after strengthening its foothold in the luxury meal delivery space, Sakara is making a bold move into the $150 billion supplement industry. The company recently launched Sakara Supplements, a premium, science-backed line of wellness products aimed at health-conscious consumers seeking high-quality, clean-label solutions.

This expansion was a natural next step for Sakara. While the brand has built a loyal following through its organic, plant-based meal programs, growth in the meal delivery sector has slowed. The supplement industry, on the other hand, continues to surge, with increasing demand for targeted, functional nutrition products. For context, the global supplement market is expected to grow at a CAGR of 8.6% through 2028, outpacing many traditional wellness categories.

By introducing supplements, Sakara is diversifying its revenue streams and positioning itself as more than just a meal delivery company, it’s evolving into a full-scale wellness empire. The move also allows Sakara to compete more directly with other premium health brands that have successfully expanded into supplements, such as Athletic Greens and Moon Juice.

More importantly, this launch could significantly boost Sakara’s financial standing. With higher profit margins than perishable food products, supplements provide a scalable and lucrative business model. If executed well, this expansion could drive long-term revenue growth and strengthen Sakara’s position in the competitive wellness market.

The question now is: Can Sakara successfully scale this new product line and capture a meaningful share of the supplement industry? Time will tell, but investors and industry watchers will be paying close attention.

More on the expansion here

What’s New?

Health

• MYndspan, a brain health technology company, has partnered with MEGIN, a leader in Magnetoencephalography (MEG) technology, to make MEG brain scans more accessible to consumers. This collaboration aims to provide non-invasive, real-time assessments of brain function, enabling early detection of neurological conditions and personalized brain health insights. Prnewswire

• ACKO, a leading technology-driven insurance company in India, offers customized health insurance plans tailored to the unique needs of families, including parents and seniors. These plans are designed to cover hospitalization expenses and more, ensuring financial protection during medical emergencies. ACKO

Nutrition

• Bruce Brown (Seraphina Therapeutics) is the new Chairman, with Karen Todd (Kyowa Hakko U.S.A.) as Chair-Elect. Several new members have joined the Board.

• At Naturally Seattle Pitch Competition applications are open for startups to compete and gain mentorship, funding, and industry exposure. wholefoodsmagazine

• OMNIA Partners Appoints Jon Garrett as Group Vice President of Food and Nutrition.

Wellness

• The FDA has lifted the shortage status of semaglutide (used in Ozempic and Wegovy), meaning Novo Nordisk can now meet demand. As a result, compounding pharmacies and digital health companies that sold off-brand versions during the shortage will face a crackdown.

• Eli Lilly has cut prices on its weight-loss drug Zepbound to stay competitive. These changes will reshape the weight-loss and diabetes medication market. Axios

Recent Scientists and Researchers Updates

• A study from the University of California, San Francisco, suggests that current "normal" levels of vitamin B12 may be insufficient to prevent dementia. Researchers found that even older adults with B12 levels above the U.S. recommended minimum exhibited slower cognitive processing and more brain lesions. This indicates a potential need to reassess B12 requirements and consider supplementation for older adults with neurological symptoms. nypost

• Allure features insights from 11 board-certified dermatologists regarding their personal use of supplements for skin and hair health. Despite the popularity of products like Nutrafol, Heliocare Advanced, Omega-3s, and vitamins D3 & K2, many dermatologists express skepticism due to limited regulation and scientific backing. Allure

Product Updates

• The Happy Mammoth recently launched 5 new supplements

Expert Opinions

• Robert F. Kennedy Jr., as HHS Secretary, prioritizes lifestyle-based health solutions, benefiting supplement makers but worrying public health experts. His "Make America Healthy Again" agenda promotes alternative medicine, opposes fluoridation, and raises vaccine misinformation concerns.

Market Insights

• Ironwood Pharmaceuticals has reported its financial results for the fourth quarter and full year 2024, successfully meeting its financial guidance. The company achieved total revenue of $351 million for the year, with a GAAP net income of $2 million and an adjusted EBITDA of $101 million.

• LINZESS® (linaclotide) experienced an 11% growth in prescription demand throughout 2024.

• Ironwood Pharmaceuticals' stock (Nasdaq: IRWD) is trading at $1.71 USD, reflecting a slight decrease of $0.035 from the previous close.

Data Insights

• Rithm Property Trust Inc. (NYSE: RPT) announced the pricing of a public offering of 2,000,000 shares of its 9.875% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock at $25.00 per share, aiming to raise $50 million before expenses.

• Warby Parker Inc. (NYSE: WRBY) has released its financial results for the fourth quarter and full year ending December 31, 2024. The company reported a 15.2% increase in full-year net revenue, totaling $771.3 million, and a 17.8% rise in fourth-quarter net revenue to $190.6 million.

Latest To Check Out:

• Ironwood announced positive data from an open-label extension study of apraglutide, a next-generation GLP-2 analog aimed at treating short bowel syndrome (SBS) patients dependent on parenteral support

• Logistics Reply has implemented its LEA Reply™ WMS for The Quality Group (TQG), the company behind the ESN and More Nutrition brands. This implementation has optimized TQG's logistics operations by enhancing stock management and order fulfillment, leading to significantly faster direct-to-consumer deliveries, even during peak periods like Black Week.

Subscribe to our newsletter for business insights, new product launches, and more health and nutrition trends that matter to you.